KKRC
AGN.PRA

Kohlberg Kravis Roberts & Co’s Allergan plc AGN.PRA Stock Holding History

Kohlberg Kravis Roberts & Co’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-8,200
Closed -$8.44M – 62
2015
Q4 		$8.44M Hold
8,200
– – 0.08% 31
2015
Q3 		$7.74M Hold
8,200
– – 0.08% 35
2015
Q2 		$8.57M Buy
+8,200
New +$8.58M 0.08% 33

Other funds holding AGN.PRA

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Kohlberg Kravis Roberts & Co's AGN.PRA Position: Q1 2016 in Review

Kohlberg Kravis Roberts & Co sold out of Allergan plc (AGN.PRA) in Q1 2016, closing a stake of 8,200 shares — an estimated $8.44M sold.

Kohlberg Kravis Roberts & Co first reported a position in AGN.PRA in Q2 2015 and held it in 3 quarters. The position peaked at $8.57M in Q2 2015. 103 funds tracked by Wall St. Rank hold AGN.PRA as of Q1 2016.

  • Kohlberg Kravis Roberts & Co reported no remaining Allergan plc position as of Q1 2016 after selling out during the quarter.
  • Kohlberg Kravis Roberts & Co sold 8,200 Allergan plc shares in Q1 2016, an estimated $8.44M.
  • Kohlberg Kravis Roberts & Co first reported a position in Allergan plc in Q2 2015 and held it in 3 quarters.
  • Kohlberg Kravis Roberts & Co's Allergan plc position peaked at $8.57M in Q2 2015.
  • 103 funds tracked by Wall St. Rank held Allergan plc as of Q1 2016.

Based on Kohlberg Kravis Roberts & Co's 13F filing for Q1 2016, filed 16 May 2016.